Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Chand Khanna
Affiliation
National Cancer Institute, National Institutes of Health
ORCID
Career Start Year
1989
Papers
156
H Index
60
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36824269
PTEN phosphatase inhibits metastasis by negatively regulating the Entpd5/IGF1R pathway through ATF6.
iScience
2023
37956387
Osteosarcoma Explorer: A Data Commons With Clinical, Genomic, Protein, and Tissue Imaging Data for Osteosarcoma Research.
JCO Clin Cancer Inform
2023
36824269
PTEN phosphatase inhibits metastasis by negatively regulating the Entpd5/IGF1R pathway through ATF6.
iScience
2023
37291042
Retrospective evaluation of the impact of hypoxemia during thoracic surgery in dogs on outcome: a multicenter analysis of 94 cases.
Vet Anaesth Analg
2023
37956387
Osteosarcoma Explorer: A Data Commons With Clinical, Genomic, Protein, and Tissue Imaging Data for Osteosarcoma Research.
JCO Clin Cancer Inform
2023
37291042
Retrospective evaluation of the impact of hypoxemia during thoracic surgery in dogs on outcome: a multicenter analysis of 94 cases.
Vet Anaesth Analg
2023
35867969
Genomic landscapes of canine splenic angiosarcoma (hemangiosarcoma) contain extensive heterogeneity within and between patients.
PLoS One
2022
35521894
Prevalence and clinical features of thoracolumbar intervertebral disc-associated epidural hemorrhage in dogs.
J Vet Intern Med
2022
35621070
A potential early clinical phenotype of necrotizing meningoencephalitis in genetically at-risk pug dogs.
J Vet Intern Med
2022
35428782
Feasibility of circulating tumor DNA analysis in dogs with naturally occurring malignant and benign splenic lesions.
Sci Rep
2022
35867969
Genomic landscapes of canine splenic angiosarcoma (hemangiosarcoma) contain extensive heterogeneity within and between patients.
PLoS One
2022
35664857
Pharmacokinetic Exposures Associated With Oral Administration of Sorafenib in Dogs With Spontaneous Tumors.
Front Vet Sci
2022
35428782
Feasibility of circulating tumor DNA analysis in dogs with naturally occurring malignant and benign splenic lesions.
Sci Rep
2022
35664857
Pharmacokinetic Exposures Associated With Oral Administration of Sorafenib in Dogs With Spontaneous Tumors.
Front Vet Sci
2022
35521894
Prevalence and clinical features of thoracolumbar intervertebral disc-associated epidural hemorrhage in dogs.
J Vet Intern Med
2022
35621070
A potential early clinical phenotype of necrotizing meningoencephalitis in genetically at-risk pug dogs.
J Vet Intern Med
2022
32666679
Identification of potential modulators of osteosarcoma metastasis by high-throughput cellular screening of natural products.
Chem Biol Drug Des
2021
33753454
Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs.
Clin Cancer Res
2021
32666679
Identification of potential modulators of osteosarcoma metastasis by high-throughput cellular screening of natural products.
Chem Biol Drug Des
2021
34687084
Leukocyte and cytokine variables in asymptomatic Pugs at genetic risk of necrotizing meningoencephalitis.
J Vet Intern Med
2021
34681195
Assessing a Novel 3D Assay System for Drug Screening against OS Metastasis.
Pharmaceuticals (Basel)
2021
33753454
Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs.
Clin Cancer Res
2021
34687084
Leukocyte and cytokine variables in asymptomatic Pugs at genetic risk of necrotizing meningoencephalitis.
J Vet Intern Med
2021
34681195
Assessing a Novel 3D Assay System for Drug Screening against OS Metastasis.
Pharmaceuticals (Basel)
2021
32458544
Prospective observational study of dogs with splenic mass rupture suggests potentially lower risk of malignancy and more favourable perioperative outcomes.
Vet Comp Oncol
2020
32458544
Prospective observational study of dogs with splenic mass rupture suggests potentially lower risk of malignancy and more favourable perioperative outcomes.
Vet Comp Oncol
2020
30939225
Polymerase chain reaction for antigen receptor rearrangement: Benchmarking performance of a lymphoid clonality assay in diverse canine sample types.
J Vet Intern Med
2019
31256903
Towards the Delivery of Precision Veterinary Cancer Medicine.
Vet Clin North Am Small Anim Pract
2019
30939225
Polymerase chain reaction for antigen receptor rearrangement: Benchmarking performance of a lymphoid clonality assay in diverse canine sample types.
J Vet Intern Med
2019
31355930
Provocative questions in osteosarcoma basic and translational biology: A report from the Children's Oncology Group.
Cancer
2019
31355930
Provocative questions in osteosarcoma basic and translational biology: A report from the Children's Oncology Group.
Cancer
2019
31256903
Towards the Delivery of Precision Veterinary Cancer Medicine.
Vet Clin North Am Small Anim Pract
2019
29334376
Positively selected enhancer elements endow osteosarcoma cells with metastatic competence.
Nat Med
2018
30061364
NCI Comparative Oncology Program Testing of Non-Camptothecin Indenoisoquinoline Topoisomerase I Inhibitors in Naturally Occurring Canine Lymphoma.
Clin Cancer Res
2018
30188888
Somatic inactivating PTPRJ mutations and dysregulated pathways identified in canine malignant melanoma by integrated comparative genomic analysis.
PLoS Genet
2018
29334376
Positively selected enhancer elements endow osteosarcoma cells with metastatic competence.
Nat Med
2018
29634688
Corrigendum: Positively selected enhancer elements endow osteosarcoma cells with metastatic competence.
Nat Med
2018
30188888
Somatic inactivating PTPRJ mutations and dysregulated pathways identified in canine malignant melanoma by integrated comparative genomic analysis.
PLoS Genet
2018
30061364
NCI Comparative Oncology Program Testing of Non-Camptothecin Indenoisoquinoline Topoisomerase I Inhibitors in Naturally Occurring Canine Lymphoma.
Clin Cancer Res
2018
29634688
Corrigendum: Positively selected enhancer elements endow osteosarcoma cells with metastatic competence.
Nat Med
2018
28926611
Activation of the unfolded protein response in sarcoma cells treated with rapamycin or temsirolimus.
PLoS One
2017
28732082
Osteosarcoma enters a post genomic era with in silico opportunities: Generation of the High Dimensional Database for facilitating sarcoma biology research: A report from the Children's Oncology Group and the QuadW Foundation.
PLoS One
2017
28460795
Obesity and Associated Comorbidities in People and Companion Animals: A One Health Perspective.
J Comp Pathol
2017
28404949
Metabolomics uncovers a link between inositol metabolism and osteosarcoma metastasis.
Oncotarget
2017
28926611
Activation of the unfolded protein response in sarcoma cells treated with rapamycin or temsirolimus.
PLoS One
2017
30050861
Tolerability of oral sorafenib in pet dogs with a diagnosis of cancer.
Vet Med (Auckl)
2017
29526259
Leveraging Comparative Oncology in the Hopes of Improving Therapies for Breast Cancer.
Semin Oncol
2017
30050861
Tolerability of oral sorafenib in pet dogs with a diagnosis of cancer.
Vet Med (Auckl)
2017
28460795
Obesity and Associated Comorbidities in People and Companion Animals: A One Health Perspective.
J Comp Pathol
2017
28404949
Metabolomics uncovers a link between inositol metabolism and osteosarcoma metastasis.
Oncotarget
2017
1 - 50 of 312
Column Actions
Search
Recommended Authors
Zhengming Chen
Weill Cornell Medicine and New York Presbyterian Hospital
Career Start Year
2013
Number of shared co-authors
0
Wendong Zhang
University of Texas MD Anderson Cancer Center
Career Start Year
2007
Number of shared co-authors
8
Jessica A Bertout
Fred Hutchinson Cancer Research Center
Career Start Year
2006
Number of shared co-authors
0
Arun S Singh
University of California-Los Angeles
Career Start Year
2006
Number of shared co-authors
2
Joseph A Ludwig
The University of Texas MD Anderson Cancer Center
Career Start Year
2005
Number of shared co-authors
14
Stacey J Adam
Foundation for the National Institutes of Health
Career Start Year
2004
Number of shared co-authors
3
Sandra J Strauss
University College London, Cancer Institute
Career Start Year
2003
Number of shared co-authors
13
Ken Kikuchi
Kyoto Prefectural University of Medicine
Career Start Year
2002
Number of shared co-authors
4
Noah Federman
University of California los angeles
Career Start Year
2001
Number of shared co-authors
8
Ping Guo
Steadman Philippon Research Institute, Center for Regenerative Sports Medicine
Career Start Year
2001
Number of shared co-authors
0
Shenghua Wen
Oncology R&D
Career Start Year
2001
Number of shared co-authors
1
Oscar M Tirado
Institut d'Investigacio Biomedica de Bellvitge (IDIBELL)/CIBERONC
Career Start Year
2000
Number of shared co-authors
13
David J Liewehr
Center for Cancer Research
Career Start Year
1999
Number of shared co-authors
13
Alana L Welm
Huntsman Cancer Institute, University of Utah
Career Start Year
1999
Number of shared co-authors
5
Annette T Byrne
Royal College of Surgeons in Ireland (RCSI)
Career Start Year
1999
Number of shared co-authors
4
Nam Bui
Stanford University
Career Start Year
1996
Number of shared co-authors
0
Stefan Sleijfer
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Career Start Year
1994
Number of shared co-authors
2
Sarah M Dry
Jonsson Comprehensive Cancer Center, University of California los angeles
Career Start Year
1992
Number of shared co-authors
2
Emile E Voest
The Netherlands Cancer Institute
Career Start Year
1989
Number of shared co-authors
2
Jose A Lopez-Martin
Hospital Universitario 12 de Octubre
Career Start Year
1988
Number of shared co-authors
2
Luc Dirix
GZA Ziekenhuizen Campus Sint-Augustinus, University of Antwerp
Career Start Year
1988
Number of shared co-authors
0
Kenneth R Hess
The University of Texas MD Anderson Cancer Center
Career Start Year
1986
Number of shared co-authors
4
Louis Gaboury
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Career Start Year
1986
Number of shared co-authors
0
David M Loeb
Children's Hospital at Montefiore.
Career Start Year
1986
Number of shared co-authors
16
Francis J Hornicek
Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami
Career Start Year
1983
Number of shared co-authors
4
John A Copland
Mayo Clinic Jacksonville
Career Start Year
1982
Number of shared co-authors
4
Adrian L Harris
University of Oxford
Career Start Year
1981
Number of shared co-authors
8
Charles Keller
Children's Cancer Therapy Development Institute
Career Start Year
1980
Number of shared co-authors
18
William E Grizzle
University of Alabama at Birmingham
Career Start Year
1974
Number of shared co-authors
2
Antonio Jimeno
University of Colorado School of Medicine
Career Start Year
1974
Number of shared co-authors
1
row(s) 1 - 30 of 30
Collaborators
Lee J Helman
Osteosarcoma Institute
Co-authored papers
33
Arnulfo Mendoza
National Cancer Institute, National Institutes of Health
Co-authored papers
28
Richard Gorlick
University of Texas MD Anderson Cancer Center
Co-authored papers
19
Paul S Meltzer
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers
14
Melissa Paoloni
Center for Cancer Research, National Cancer Institute
Co-authored papers
13
Stephen M Hewitt
Center for Cancer Research, National Cancer Institute
Co-authored papers
13
Javed Khan
Center for Cancer Research, National Cancer Institute
Co-authored papers
11
Choh Yeung
Center for Cancer Research, National Cancer Institute
Co-authored papers
10
Donald A Barkauskas
Keck School of Medicine of the University of Southern California
Co-authored papers
8
Qing-Rong Chen
Center for Biomedical Informatics and Information Technology
Co-authored papers
7
Susan E Lana
College of Veterinary Medicine and Biomedical Sciences, Colorado State University
Co-authored papers
7
Lisa Mirabello
National Cancer Institute
Co-authored papers
7
Glenn Merlino
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers
6
Piero Picci
IRCCS Istituto Ortopedico Rizzoli
Co-authored papers
6
Sharon A Savage
Clinical Genetics Branch, National Cancer Institute (NCI)
Co-authored papers
6
Katherine A Janeway
Co-authored papers
6
Stephen J Withrow
College of Veterinary Medicine and Biomedical Sciences, Colorado State University
Co-authored papers
5
Irene L Andrulis
University of Toronto
Co-authored papers
5
Neyssa Marina
Stanford University School of Medicine
Co-authored papers
5
Stephen J Chanock
National Cancer Institute, National Institutes of Health
Co-authored papers
5
Luis Sierrases??maga
Clinica Universidad de Navarra
Co-authored papers
4
Nalan Gokgoz
Lunenfeld-Tanenbaum Research Institute
Co-authored papers
4
Fernando Lecanda
University of Navarra, Center for Applied Medical Research
Co-authored papers
4
Meredith Yeager
Frederick National Laboratory for Cancer Research
Co-authored papers
4
Jay S Wunder
University of Toronto
Co-authored papers
4
Peter C Scacheri
Case Western Reserve University School of Medicine
Co-authored papers
4
Jeffrey A Toretsky
Georgetown University Medical Center, Georgetown University
Co-authored papers
4
Malcolm A Smith
National Cancer Institute
Co-authored papers
4
Julie M Gastier-Foster
Baylor College of Medicine
Co-authored papers
4
Ching C Lau
Baylor College of Medicine
Co-authored papers
4
1 - 30